Icotyde is a prescription medication indicated for the treatment of moderate-to-severe plaque psoriasis in patients 12 years of age and older who weigh at least 40 kg and are candidates for systemic therapy or phototherapy.

Unlike topical treatments, Icotyde is intended for patients requiring systemic intervention, helping manage widespread or treatment-resistant disease. It works by targeting underlying inflammatory pathways involved in psoriasis, reducing plaque formation and skin inflammation.

Plaque psoriasis is a chronic autoimmune condition that can significantly impact quality of life, causing discomfort, visible skin lesions, and psychosocial burden. Effective systemic therapies like Icotyde can help improve symptom control and disease management.

Icotyde is used under medical supervision, with treatment tailored based on patient response and clinical severity.